Determining treatment choices after the cochlear implant evaluation process
| Autor: | Theresa Hammer, Kareem Tawfik, Andrew J. Redmann, Shawn M. Stevens, Ravi N. Samy, Lisa Wenstrup, Joseph T. Breen |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Hearing aid
Pediatrics medicine.medical_specialty Adult patients Treatment choices business.industry medicine.medical_treatment lcsh:Surgery General Medicine Evidence-based medicine lcsh:RD1-811 lcsh:Otorhinolaryngology lcsh:RF1-547 Neurotology cochlear implants Cochlear implant medicine Candidacy evaluation process Otology Neurotology and Neuroscience Cochlear implantation business treatment pathways Original Research |
| Zdroj: | Laryngoscope Investigative Otolaryngology Laryngoscope Investigative Otolaryngology, Vol 6, Iss 2, Pp 320-324 (2021) |
| ISSN: | 2378-8038 |
| Popis: | Objectives Determine the proportion of patients starting the cochlear implant evaluation (CIE) process proceeding to cochlear implantation. Determine which patient factors are associated with undergoing cochlear implantation Methods Retrospective case series of all patients scheduled for a CIE within a tertiary academic neurotology practice between January 1, 2014 and April 30, 2016. Management pathways of patients undergoing CIE were examined. Results Two hundred thirty‐seven adult patients were scheduled for CIE during the study period. Two hundred twenty‐six patients started the evaluation process, and 203 patients completed full evaluation. Of patients that completed CIE, 166/203 (82%) met criteria for implantation and 37/203 (18%) did not meet criteria. Fifty‐nine patients out of 166 patients (36%) meeting criteria did not receive implants and 107/166 (64%) underwent implantation, yielding an overall implantation rate of 47% (107/226) among patients scheduled for CIE. Common reasons for deferring CI among candidates included failure to show up for preoperative appointment (24%), choosing hearing aids as an alternative (22%), patient refusal (21%) and insurance issues (17%). Overall, CIE led to a new adjunctive hearing device (CI or hearing aid) in 113 (113/203, 56%) cases. Conclusion Fifty‐six (113/203) percent of patients who underwent CIE at an academic medical center underwent CI surgery or received an adjunctive hearing device, but 36% (59/166) of candidates did not receive a CI. Patients who forewent CI despite meeting candidacy criteria did so due to cost/insurance issues, or due to preference for auditory amplification rather than CI. Level of evidence 4. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text